Surgery for Non Small Cell Lung Cancer - A Systematic Review
Journal: International Journal of Science and Research (IJSR) (Vol.11, No. 5)Publication Date: 2022-05-05
Authors : Ilir Skenduli; Perlat Kapisyzi;
Page : 1551-1556
Keywords : non small cell lung cancer; lobectomy; pneumonectomy; sublobar resection; surgery;
Abstract
The management strategy for the treatment of non-small-cell lung cancer (NSCLC) has been transformed by our improved understanding of the cancer biology and concomitant development of novel systemic therapies. Complete surgical resection of NSCLC continues to offer the best chance for cure or local and regional disease control and with improvements in minimally invasive techniques and enhanced recovery, the morbidity associated with surgical resection has been reduced. Patient-centered multi-disciplinary discussions that consider surgical therapy are associated with improved outcomes. Provided with promising novel therapeutic modalities including immune checkpoint inhibitors with or without chemotherapy, stereotactic radiotherapy, and targeted systemic therapies, indications for surgery continue to evolve and have expanded to include selected patients with advanced and metastatic disease.
Other Latest Articles
- Prima Facie for Gender Budgeting: A Key to Gender Equality in India
- Advancement in Edible Medicated Jelly
- Secondary Traumatic Stress, Romantic Relationship Satisfaction and Burnout Syndrome in Psychologists and Doctors in Maharashtra
- Electrocoagulation Treatment of Municipal Waste Water
- Quality Orientation, Quality Management Tools & Techniques and Firm Performance: A Review
Last modified: 2022-09-07 15:14:21